Plasmacytoid Dendritic Cell Neoplasm

Observed

→ investigated in trials for

Fludarabinesmall molecule

9 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tagraxofuspother

8 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Venetoclaxsmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall molecule

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thiotepasmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Azacitidinesmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cytarabinesmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rituximabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Busulfansmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ibuprofensmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mercaptopurinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Prednisonesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Plasmacytoid Dendritic Cell Neoplasm studied in …STUDIED_INderived10 of 41show all (up to 200)
→ studied in	NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07785180recruiting A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04216524Phase 2 · recruiting Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06765876early Phase 1 · active not recruiting CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03386513Phase 1/Phase 2 · active not recruiting Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06690827Phase 1 · recruiting Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN · condition mapped ALIAS · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02159495Phase 1 · active not recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07785154recruiting A Registry-study of ELZONRIS in Participants With BPDCN · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04013685Phase 1 · active not recruiting Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)	—	—	Blastic Plasmacytoid Dendritic Cell Neoplasm	1	Observed	clinicaltrials	graph →

Plasmacytoid Dendritic Cell Neoplasm studied in …STUDIED_INderived10 of 41show all (up to 200)

→ studied in

NCT03779854Phase 2 · active not recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT07785180recruiting

A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT04216524Phase 2 · recruiting

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT06765876early Phase 1 · active not recruiting

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT07819396Phase 2 · not yet recruiting

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT03386513Phase 1/Phase 2 · active not recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT06690827Phase 1 · recruiting

Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN · condition mapped ALIAS · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT02159495Phase 1 · active not recruiting

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT07785154recruiting

A Registry-study of ELZONRIS in Participants With BPDCN · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed

→ studied in

NCT04013685Phase 1 · active not recruiting

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 41 trials mapped (19 active)

—

Observed